Evaluation of Quantitative PCR and Branched-Chain DNA Assay for Detection of Hepatitis B Virus DNA in Sera from Hepatocellular Carcinoma and Liver Transplant Patients-Reference-Cited by-同舟云学术

Evaluation of Quantitative PCR and Branched-Chain DNA Assay for Detection of Hepatitis B Virus DNA in Sera from Hepatocellular Carcinoma and Liver Transplant Patients

Published:2000-05 Issue:5 Volume:38 Page:1977-1980
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Chen Tao¹,Luk John M.¹,Cheung Siu-Tim¹,Yu Wan-Ching¹,Fan Sheung-Tat¹

Affiliation:

1. Center of Liver Diseases and Department of Surgery, University of Hong Kong Medical Center, Queen Mary Hospital, Pokfulam, Hong Kong

Abstract

ABSTRACT This study evaluated the applicability of quantitative PCR (Q-PCR) and branched-chain DNA assays for detection of hepatitis B virus (HBV) DNA in sera. For 42 samples, the detection rates were 81 and 41%, respectively, with a correlation coefficient of 0.633. The Q-PCR is useful for early monitoring of HBV load in high-risk patients.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.38.5.1977-1980.2000

Reference24 articles.

1. Review: hepatitis B and liver transplantation;Angus P. W.;J. Gastroenterol. Hepatol.,1997

2. Hepatitis B virus. The major etiology of hepatocellular carcinoma;Beasley R. P.;Cancer,1988

3. Mini-pool screening by nucleic acid testing for hepatitis B virus, hepatitis C virus, and HIV: preliminary results;Cardoso M. S.;Transfusion,1998

4. Hepatitis B virus replication status and its response to surgery for tumor in hepatocellular carcinoma with positive markers of HBV;Chen T.;Chin. J. Surgery,1998

5. Comparative evaluation of hepatitis C virus RNA quantitation by branched DNA, NASBA, and Monitor assays;Francoise L.;Hepatology,1999

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polymorphism of TLR5 rs5744174 is associated with disease progression in Chinese patients with chronic HBV infection;APMIS;2017-05-25

2. Anti-Hepatitis B Virus X Protein in Sera Is One of the Markers of Development of Liver Cirrhosis and Liver Cancer Mediated by HBV;Journal of Biomedicine and Biotechnology;2009

3. A review of the one-year incidence of resistance to lamivudine in the treatment of chronic hepatitis B;Hepatology International;2008-10-21

4. Cost-effectiveness of suppressing hepatitis B virus DNA in immune tolerant patients to prevent hepatocellular carcinoma and cirrhosis;Alimentary Pharmacology & Therapeutics;2007-05-25

5. Expertise of Laboratories in Viral Load Quantification, Genotyping, and Precore Mutant Determination for Hepatitis B Virus in a Multicenter Study;Journal of Clinical Microbiology;2006-10